Abstract
One of the major causes of mortality and morbidity in Behcet's disease (BD) is vascular involvement. Limited data suggest a high prevalence of venous insufficiency (VI) and some cases of asymptomatic thrombosis in BD. In this study, we aimed to investigate asymptomatic venous disease by venous Doppler ultrasonography (US) prospectively in patients with BD, without known vascular disease. The study included 93 patients with BD (M/F, 45/48; age, 36.4 ± 10 years), 97 patients with ankylosing spondylitis (AS) (M/F, 50/47; age, 37.5 ± 9.5 years), and 43 healthy controls (HC) (M/F, 25/18; age, 34.7 ± 4.5 years). All patients were examined for the clinical findings of venous thrombosis. Vessels of both upper and lower extremities were examined, while the subjects were in supine position by venous Doppler US. Clinical signs (“C”), the various etiologies (“E”), anatomical sites (“A”), and pathophysiological disorder (“P”) (CEAP) severity score was used to evaluate the severity of the VI. We did not detect any “silent thrombosis” in any group. VI findings in lower extremity were detected in 32.2 % (n = 30) in the BD group, 28.8 % (n = 28) in AS group, and 9.3 % (n = 4) in the HC group. Both BD and AS patients had significantly higher VI rates than controls (p = 0.007 and 0.015). Similarly, CEAP severity score in BD (0.34 (0–3)) was significantly higher than controls (0, p = 0.008) but similar to AS (0.18 (0–39), p = 0.18). No correlations were present between C-reactive protein elevation (>5 mg/L) and VI in both BD (p = 0.546) and AS (p = 0.754). A high prevalence of VI was present in both BD and AS patients without symptomatic thrombosis. Presence of VI also in AS, a disease without a major tendency to venous thrombosis, might suggest that chronic inflammation might cause a mild insufficiency detected only by Power US in venous vessels. Long-term consequences of this finding require further follow-up studies to show whether asymptomatic venous disease is a predictor of future venous thrombotic events in patients with BD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl 341:1284–1291
Direskeneli H (2001) Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60(11):996–1002, Review. No abstract available
Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007) The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease. Clin Exp Rheumatol 25(4 Suppl 45):S27–S33
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M et al (2010) Mortality in Behcet's disease. Arthritis Rheum 62:2806–2812
Kisacik B, Oren C, Kasifoglu T, Yilmaz S, Yilmaz O, Simsek I et al (2012) Investigation of the veins in patients with Behçet's disease with no known vascular event by Doppler ultrasonography. Rheumatol Int 32(2):303–306. doi:10.1007/s00296-010-1603-2
International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078–1080
Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368
Nicolaides AN MS, FRCS, FRCSE (2000) Investigation of chronic venous insufficiency. Consensus Statement Circ 102:e126–e163
Labropoulos N, Tiongson J, Pryor L et al (2003) Definition of venous reflux in lower-extremity veins. J Vasc Surg 38:793–798
Aksu K, Donmez A, Keser G (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 18(11):1478–93, Review
Pay S, Simsek I, Erdem H, Dinç A (2007) Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 27:417–424
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Expert Committee EULAR et al (2008) EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 67(12):1656–1662. doi:10.1136/ard.2007.080432
Hatemi G, Fresko I, Tascilar K, Yazici H (2008) Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 58(5):1539–1545. doi:10.1002/art.23450
Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N et al (2013) Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet. doi:10.1038/ng.2551
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R–IL12RB2 regions associated with Behçet's disease. Nat Genet 42(8):698–702. doi:10.1038/ng.625
Kuzu A, Köksoy C, Ozaslan C, Gürler A, Tüzüner A (1996) Evaluation of peripheral vascular system disorders in vascular symptom-free Behçet's disease. Cardiovasc Surg 4(3):381–383
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alibaz-Oner, F., Karatay, E., Akpinar, I.N. et al. Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis. Clin Rheumatol 33, 277–280 (2014). https://doi.org/10.1007/s10067-013-2382-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2382-4